GILD - GILEAD SCIENCES, INC.
147.83
-2.200 -1.488%
Share volume: 6,356,236
Last Updated: 03-03-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.31%
PREVIOUS CLOSE
CHG
CHG%
$150.03
-2.20
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-08-2024 | 11-12-2024 | 02-28-2025 | 05-07-2025 | 08-07-2025 | 11-07-2025 | 02-24-2026 | |
| Assets | |||||||||
| Total Assets | 56.292 B | 53.579 B | 54.525 B | 58.995 B | 56.434 B | 55.721 B | 58.533 B | 59.023 B | |
| Current Assets | 14.041 B | 12.317 B | 14.779 B | 19.173 B | 16.901 B | 14.718 B | 17.874 B | 18.342 B | |
| Inventories | 1.853 B | 2.026 B | 1.869 B | 1.710 B | 1.759 B | 1.825 B | 1.785 B | 1.774 B | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 69.000 M | 19.000 M | 68.000 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 4.718 B | 2.772 B | 5.037 B | 9.991 B | 7.926 B | 5.144 B | 7.330 B | 7.564 B | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 1.913 B | 2.005 B | 2.974 B | |
| Property Plant Equipment | 5.321 B | 5.346 B | 5.391 B | 5.414 B | 5.421 B | 5.459 B | 5.500 B | 5.606 B | |
| Other Assets | 36.930 B | 35.916 B | 34.354 B | 34.408 B | 34.112 B | 35.545 B | 35.160 B | 35.075 B | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 56.292 B | 53.579 B | 54.525 B | 58.995 B | 56.434 B | 55.721 B | 58.533 B | 59.023 B | |
| Total liabilities | 38.837 B | 35.384 B | 36.134 B | 39.749 B | 37.355 B | 36.130 B | 37.078 B | 36.405 B | |
| Total current liabilities | 13.015 B | 10.781 B | 11.725 B | 12.004 B | 12.344 B | 11.189 B | 12.298 B | 11.813 B | |
| Accounts Payable | 622.000 M | 537.000 M | 903.000 M | 833.000 M | 737.000 M | 582.000 M | 808.000 M | 715.000 M | |
| Other liabilities | 1.395 B | 1.418 B | 1.396 B | 1.295 B | 1.337 B | 1.290 B | 1.182 B | 1.165 B | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 21.527 B | 21.540 B | 21.437 B | 24.896 B | 22.146 B | 22.140 B | 22.135 B | 22.129 B | |
| Other liabilities | 1.395 B | 1.418 B | 1.396 B | 1.295 B | 1.337 B | 1.290 B | 1.182 B | 1.165 B | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 17.539 B | 18.281 B | 18.474 B | 19.330 B | 19.162 B | 19.675 B | 21.540 B | 22.702 B | |
| Common stock | 6.814 B | 7.023 B | 7.328 B | 7.701 B | 8.139 B | 8.368 B | 8.679 B | 8.933 B | |
| Retained earnings | 10.656 B | 11.165 B | 11.073 B | 11.497 B | 10.931 B | 11.325 B | 12.825 B | 13.730 B |